Toronto Dominion Bank’s AMAG Pharmaceuticals AMAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-60
Closed 1759
2019
Q2
$0 Buy
+60
New +$647 ﹤0.01% 1862
2014
Q3
Sell
-1,373
Closed -$28K 1077
2014
Q2
$28K Sell
1,373
-8,927
-87% -$165K ﹤0.01% 962
2014
Q1
$199K Buy
+10,300
New +$219K ﹤0.01% 702
2013
Q4
Sell
-4,977
Closed -$107K 1063
2013
Q3
$107K Buy
4,977
+4,598
+1,213% +$109K ﹤0.01% 568
2013
Q2
$8K Buy
+379
New +$8.35K ﹤0.01% 732

Other funds holding AMAG

Toronto Dominion Bank's AMAG Position: Q3 2019 in Review

Toronto Dominion Bank sold out of AMAG Pharmaceuticals (AMAG) in Q3 2019, closing a stake of 60 shares.

Toronto Dominion Bank first reported a position in AMAG in Q2 2013 and held it in 5 quarters. The position peaked at $199K in Q1 2014. 156 funds tracked by Wall St. Rank hold AMAG as of Q3 2019.

  • Toronto Dominion Bank reported no remaining AMAG Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Toronto Dominion Bank sold 60 AMAG Pharmaceuticals shares in Q3 2019.
  • Toronto Dominion Bank first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • Toronto Dominion Bank's AMAG Pharmaceuticals position peaked at $199K in Q1 2014.
  • 156 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2019.

Based on Toronto Dominion Bank's 13F filing for Q3 2019, filed 12 Nov 2019.